睡眠引進劑的全球市場:2022年~2028年
市場調查報告書
商品編碼
1123086

睡眠引進劑的全球市場:2022年~2028年

Global Sleep Aid Market Research and Forecast 2022-2028

出版日期: | 出版商: Orion Market Research | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

全球睡眠引進劑的市場規模在預測期間內預計將以7.0%的年複合成長率擴大。推動市場增長的因素包括老年人口的增加和睡眠障礙的發病率增加。

本報告提供全球睡眠引進劑市場相關調查,提供市場概要,以及睡眠障礙,各產品,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
  • 主要策略分析
  • COVID-19對主要加入企業帶來的影響

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 機會

第5章 市場區隔

  • 全球睡眠引進劑市場,睡眠障礙
    • 失眠症
    • 睡眠呼吸中止症
    • 猝睡症
    • 夢遊症
    • 不寧腿症候群
  • 全球睡眠引進劑市場,各產品
    • 睡眠研究服務
    • 特殊床墊和枕頭
    • 投藥
    • 睡眠呼吸中止症設備

第6章 地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第7章 企業簡介

  • Apex Medical Corp.
  • Braebon Medical Corp
  • Cadwell Industries Inc.
  • Compumedics Ltd.
  • DeVilbiss Healthcare LLC
  • Fisher & Paykel Healthcare Ltd.
  • General Electric Co.
  • GlaxoSmithKline plc
  • Invacare Corp.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Merck & Co., Inc.
  • Natus Medical Inc.
  • Pfizer Inc.
  • ResMed Corp.
  • Sanofi S.A.
  • SleepMed, Inc.
  • SomnoMed Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
Product Code: MD-1220

Global Sleep Aid Market Size, Share & Trends Analysis Report by Sleep Disorder (Insomnia, Sleep Apnea, Narcolepsy, Sleep Walking, and Restless Legs Syndrome), By Products (Sleep Laboratories Services, Specialty Mattresses and Pillows, Medications, and Sleep Apnea Devices) Forecast, 2021-2027

The global sleep aid market is anticipated to grow significantly at a CAGR of 7.0% during the forecast period. The factors that are driving the growth of the market include the rising geriatric population and increasing incidences of sleep disorders. For instance, according to the Sleep Foundation, in the US, the number of people with more than 65 years was 15% in 2016 and expected to have 21% by 2040 of the US population. This trend continues to be experienced globally, as the United Nations estimation that the number of people with more than 60 years will be double by 2050, and Triple by 2100. Aging is linked to a variety of health issues, including sleep problems. In reality, lack of sleep can contribute to a variety of issues, lowering the quality of life in adults over the age of 65.

Several common disturbances found in older adults such as walking up at night, daytime napping, and sleep issues occurs such as nighttime urination, pain, insomnia, sleep apnea, restless leg syndrome, and daytime drowsiness, among others. Among these, sleep apnea is a sleep breathing disorder in which the upper airway collapses during sleep. It has an impact on sleep quality and daily weariness, as well as being a risk factor for hypertension, heart disease, stroke, and sudden death while sleeping, it most commonly observed in elderly people. The factors that are restraining the growth of the market include shortage of skilled medical professionals, patent expiration of sleep disorder medications, and side effects associated with the sleep medications, among others. Moreover, the increase in awareness about sleep disorders and technological advancements are expected to create new market opportunities to sleep aids manufacturers during the forecast period.

Impact of COVID-19 Pandemic on Global Sleep Aid Market

The global sleep aid market is hit by the outbreak of COVID-19 in December 2019. The pandemic has caused unprecedented changes in the healthcare systems. During lockdown across the globe, the habit of people changed for everything, in which mental health problems have been noticed. Sleep disorders were one of the major mental health problems, as solid sleep was neglecting due to the changed schedule. Sleep aids are medications and surgical instruments used to detect and cure sleep disorders. Increasing working hours, job burden, hectic working environment, among others, have been noticed as work from the home model was taking place during the pandemic. The various people lost their jobs has lead to anxiety and hypertension and lack of sleep. As the re-opening of the economy positively affect the sleep aid market. The market will witness "V" shape recovery in near future owing to the restart of activities in major economies.

Segmental Outlook

The global sleep aid market can be segmented based on sleep disorders, and products. Based on the sleep disorder, the market is classified into insomnia, sleep apnea, narcolepsy, sleepwalking, and restless legs syndrome. Based on the products, the market is classified into sleep laboratories services, specialty mattresses and pillows, medications, and sleep apnea devices. Besides, the medications segment is classified into prescription drugs, OTC drugs, and herbal drugs. Apart from it, sleep apnea devices are segmented into diagnostics devices and therapeutic devices.

Global Sleep Aid Market Share by Sleep Disorder, 2020 (%)

Global Sleep Aid Market Share by Sleep Disorder

Insomnia Segment holds a significant share in the Global Sleep Aid Market

Among the sleep disorders for the global sleep aid market, the insomnia segment held the highest share in 2020 and is also anticipated to grow significantly during the forecast period. The incidence of insomnia in people increases due to work stress, depression, anxiety disorders, excessive smoking, and alcohol consumption. Insomnia is one of the most prevalent sleep disorders among older persons is continuous trouble falling or staying asleep. Insomnia can be caused by several interconnected reasons, but it can be improved with treatment. According to the Sleep Foundation, 10% to 30% of adults in the US live with insomnia, and 30% to 48% of elder people live with insomnia in the US.

Regional Outlooks

The global sleep aid market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others), and the Rest of the World (the Middle East and Africa, and Latin America). North America has been predicted to dominate the global sleep aid market. The growth is mainly attributed due to increased health care expenditure, a huge population with a sleep disorder, and higher awareness regarding sleep disorders. For instance, according to the National Health Expenditure Accounts (NHEA), In 2019, US healthcare spending increased by 4.6 % to $3.8 trillion, or $11,582 per person. Health spending accounted for 17.7 % of the nation's Gross Domestic Product. Apart from it, as per the American Sleep Association, around 60% of the US population experience insomnia, and more than 15% of the population in the US experience sleep apnea, which led to higher demand for treatment.

Global Sleep Aid Market Growth, by Region 2021-2027

Global Sleep Aid Market Growth, by Region

Asia-Pacific is projected to have considerable growth in the Global Sleep Aid Market

Asia-Pacific is anticipated to exhibit significant growth in the global sleep aid market. In the region, countries such as China and India are the most promising economies in terms of growth. This is attributable to the increased prevalence of cases of insomnia. The market for sleep aids is being driven by a rise in the young population, increasing consumption of alcohol and tobacco, stressful working hours, and a lifestyle change. For instance, increasing working hours, heavy workloads and work pressures, and a stressful work atmosphere all contribute to increased stress levels and poor sleep quality. As a result, sales of over-the-counter (OTC) sleeping medicines, which support enhancing sleep quality, across the region.

Market Players Outlook

The key players of the global sleep aid market include Apex Medical Corp., Cadwell Industries Inc., General Electric Co., GlaxoSmithKline Plc, Koninklijke Philips N.V., Merck & Co., Pfizer Inc., Sanofi S.A., SleepMed Inc., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2018, Koninklijke Philips N.V., a global leader in health technology, announced that it has acquired NightBalance, a digital health scale-up based in the Netherlands that has developed an innovative, user-friendly device to treat positional obstructive sleep apnea and snoring.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global sleep aid market.

Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Sleep AidIndustry
  • Recovery Scenario of Global Sleep AidIndustry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Sleep Aid Market by Sleep Disorder
    • 5.1.1. Insomnia
    • 5.1.2. Sleep Apnea
    • 5.1.3. Narcolepsy
    • 5.1.4. Sleep Walking
    • 5.1.5. Restless Legs Syndrome
  • 5.2. Global Sleep Aid Market by Products
    • 5.2.1. Sleep Laboratories Services
    • 5.2.2. Specialty Mattresses and Pillows
    • 5.2.3. Medications
      • 5.2.3.1. Prescription Drugs
      • 5.2.3.2. OTC Drugs
      • 5.2.3.3. Herbal Drugs
    • 5.2.4. Sleep Apnea Devices
      • 5.2.4.1. Diagnostics Devices
      • 5.2.4.2. Therapeutic Devices

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Apex Medical Corp.
  • 7.2. Braebon Medical Corp
  • 7.3. Cadwell Industries Inc.
  • 7.4. Compumedics Ltd.
  • 7.5. DeVilbiss Healthcare LLC
  • 7.6. Fisher & Paykel Healthcare Ltd.
  • 7.7. General Electric Co.
  • 7.8. GlaxoSmithKline plc
  • 7.9. Invacare Corp.
  • 7.10. Koninklijke Philips N.V.
  • 7.11. Medtronic PLC
  • 7.12. Merck & Co., Inc.
  • 7.13. Natus Medical Inc.
  • 7.14. Pfizer Inc.
  • 7.15. ResMed Corp.
  • 7.16. Sanofi S.A.
  • 7.17. SleepMed, Inc.
  • 7.18. SomnoMed Inc.
  • 7.19. Takeda Pharmaceutical Co. Ltd.
  • 7.20. Teva Pharmaceutical Industries Ltd.

LIST OF TABLES

  • 1. GLOBAL SLEEP AID MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 2. GLOBAL SLEEP AID MARKET RESEARCH AND ANALYSIS BY SLEEP DISORDER, 2020-2027 ($ MILLION)
  • 3. GLOBAL INSOMNIA IN SLEEP AID MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL SLEEP APNEA IN SLEEP AID MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL NARCOLEPSY IN SLEEP AID MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL SLEEP WALKING IN SLEEP AID MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL RESTLESS LEGS SYNDROME IN SLEEP AID MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL SLEEP AID MARKET RESEARCH AND ANALYSIS BY PRODUCTS, 2020-2027 ($ MILLION)
  • 9. GLOBAL SLEEP LABORATORIES FOR SLEEP AID MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL SPECIALTY MATTRESSES AND PILLOWS FOR SLEEP AID MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL MEDICATIONS FOR SLEEP AID MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL MEDICATIONS FOR SLEEP AID MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 13. GLOBAL SLEEP APNEA DEVICES FOR SLEEP AID MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL SLEEP APNEA DEVICES FOR SLEEP AID MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 15. NORTH AMERICAN SLEEP AID MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 16. NORTH AMERICAN SLEEP AID MARKET RESEARCH AND ANALYSIS BY SLEEP DISORDER, 2020-2027 ($ MILLION)
  • 17. NORTH AMERICAN SLEEP AID MARKET RESEARCH AND ANALYSIS BY PRODUCTS, 2020-2027 ($ MILLION)
  • 18. EUROPEAN SLEEP AID MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 19. EUROPEAN SLEEP AID MARKET RESEARCH AND ANALYSIS BY SLEEP DISORDER, 2020-2027 ($ MILLION)
  • 20. EUROPEAN SLEEP AID MARKET RESEARCH AND ANALYSIS BY PRODUCTS, 2020-2027 ($ MILLION)
  • 21. ASIA-PACIFIC SLEEP AID MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 22. ASIA-PACIFIC SLEEP AID MARKET RESEARCH AND ANALYSIS BY SLEEP DISORDER, 2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC SLEEP AID MARKET RESEARCH AND ANALYSIS BY PRODUCTS, 2020-2027 ($ MILLION)
  • 24. REST OF THE WORLD SLEEP AID MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 25. REST OF THE WORLD SLEEP AID MARKET RESEARCH AND ANALYSIS BY SLEEP DISORDER, 2020-2027 ($ MILLION)
  • 26. REST OF THE WORLD SLEEP AID MARKET RESEARCH AND ANALYSIS BY PRODUCTS, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL SLEEP AID MARKET, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL SLEEP AID MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL SLEEP AID MARKET, 2021-2027 (%)
  • 4. GLOBAL SLEEP AID MARKET SHARE BY SLEEP DISORDER, 2020 VS 2027 (%)
  • 5. GLOBAL SLEEP AID MARKET SHARE BY PRODUCTS, 2020 VS 2027 (%)
  • 6. GLOBAL SLEEP AID MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 7. GLOBAL INSOMNIA IN SLEEP AID MARKET SHARE BY REGION, 2020 VS 2027(%)
  • 8. GLOBAL SLEEP APNEA IN SLEEP AID MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 9. GLOBAL NARCOLEPSY IN SLEEP AID MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL SLEEP WALKING IN SLEEP AID MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL RESTLESS LEGS SYNDROME IN SLEEP AID MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL SLEEP LABORATORIES FOR SLEEP AID MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL SPECIALTY MATTRESSES AND PILLOWS FOR SLEEP AID MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL MEDICATIONS FOR SLEEP AID MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 15. GLOBAL MEDICATIONS FOR SLEEP AID MARKET SHARE BY TYPE, 2020 VS 2027 (%)
  • 16. GLOBAL SLEEP APNEA DEVICES FOR SLEEP AID MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 17. GLOBAL SLEEP APNEA DEVICES FOR SLEEP AID MARKET SHARE BY TYPE, 2020 VS 2027 (%)
  • 18. US SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. CANADA SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. UK SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. FRANCE SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. GERMANY SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. ITALY SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. SPAIN SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. REST OF EUROPE SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. INDIA SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. CHINA SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. JAPAN SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. SOUTH KOREA SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. REST OF THE ASIA-PACIFIC SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)
  • 31. REST OF THE WORLD SLEEP AID MARKET SIZE, 2020-2027 ($ MILLION)